CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent ...
A novel PET perfusion radiotracer, 18 F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99m Tc-SPECT myocardial ...
In a recent study published in Scientific Reports, researchers investigated the performance of a machine learning (ML)-based model in evaluating radiomic features to diagnose coronary artery disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback